ROSALIA TRETO: Open Payments
NPI 1902363963 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,681 in 82 payments from 20 companies in 2025. Trend: 2023 $69 · 2024 $5,397 · 2025 $2,681
Food & beverage: $2,005Speaker / faculty: $560Education: $116
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 9 | $692 |
| ABBVIE INC. | 20 | $610 |
| Madrigal Pharmaceuticals | 8 | $314 |
| Janssen Biotech, Inc. | 9 | $261 |
| Lilly USA, LLC | 9 | $259 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $87 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $67 |
| Aimmune Therapeutics, Inc. | 3 | $59 |
| Novo Nordisk Inc | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
Products named: VOQUEZNA, REZDIFFRA, OMVOH, TREMFYA, CREON, LINZESS, RINVOQ, MAVYRET.
Industry payments across TX — which companies pay providers there.
